On May 8th, 2019, David Weingard, Founder and CEO of Cecelia Health, will moderate a panel discussion at the MM&M Transforming Healthcare conference. The conference takes place at the Edison Ballroom in New York City.
Panel: The Future of Value-Based Reimbursement and Care
May 8, 2019, 11:50 A.M. – 12:30 P.M.
For all the talk of performance-based contracting in healthcare, there are few value-based agreements that carry true upside/downside risk for the players, nor have such agreements often involved more than two parties. We highlight the shift in care pathways and the novel reimbursement structure which has pharma, device, payer, and health tech forces coming together in disruptive fashion, to accelerate the acceptance of real-world evidence as a standard in our industry. Join us as we discuss the future of care and reimbursement for disease states like diabetes, COPD and much more!
- Kurt Hudson, franchise director, Acelity’s Surgical and Sports Medicine Business
- Peter Lynch, VP, global access, Dexcom
- Steven R. Peskin, MD, executive medical director, population health, Horizon Blue Cross Blue Shield of New Jersey
- Mark Vineis, VP, market access and commercialization, Novartis
About MM&M Transforming Healthcare
Transforming Healthcare provides the venue for convergence of the worlds of health-tech startups, VC, and all of the big healthcare industry stakeholders. MM&M Transforming Healthcare features talks by high-level Transformers, cutting-edge educational content on integrating new technology with old, thought-provoking panels on the questions raised by convergence, and unparalleled networking for attendees.